CIK: 0001560009
Total reported value
$141.4M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | GLUE | Monte Rosa Therapeutics INC | Stock-Other | 43.56% | -8.49% | — | |
| 2 | CRSP | CRISPR Therapeutics AG | Stock-Healthcare | 28.18% | -0.16% | — | |
| 3 | CTNM | Contineum Therapeutics Inc-a | Stock-Other | 10.64% | +0.90% | — | |
| 4 | SKYE | Skye Bioscience INC | Stock-Other | 5.30% | -0.13% | — | |
| 5 | RPTX | Repare Therapeutics INC | Stock-Other | 4.33% | — | — | |
| 6 | TPST | Tempest Therapeutics INC | Stock-Other | 4.30% | — | — | |
| 7 | ADVMCHF | Adverum Biotechnologies INC | Stock-Other | 3.68% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | GLUE | Monte Rosa Therapeutics INC | — | NEW | New buy |
| 2 | CRSP | CRISPR Therapeutics AG | — | NEW | New buy |
| 3 | CTNM | Contineum Therapeutics Inc-a | — | NEW | New buy |
| 4 | SKYE | Skye Bioscience INC | — | NEW | New buy |
| 5 | RPTX | Repare Therapeutics INC | — | NEW | New buy |
| 6 | TPST | Tempest Therapeutics INC | — | NEW | New buy |
| 7 | ADVMCHF | Adverum Biotechnologies INC | — | NEW | New buy |